Hyperglycemia: Clinical Trials

93 trials for Hyperglycemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

93 completed. 93 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 493Completed 93

Follow Hyperglycemia: new trials by email Literature Review of Hyperglycemia trials Research Report on Hyperglycemia

Trials (filtered) newest first · largest first

All 93 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Metformin, Dulaglutide, Semaglutide 1.0 mg - Diabetes Mellitus Type 2
Phase 4CompletedFundación para la Investigación del Hospital Clínico de Valencia922025-05-262026-09-04
Metformin Use in Patients Undergoing Total Joint Replacement Surgery
Metformin, Placebo - Hyperglycemia
Phase 4CompletedOregon Health and Science University402024-06-272025-12-05
Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction
Dapagliflozin 10mg/Tab, control group - Myocardial Infarction, Diabete Type 2
Phase 4CompletedQingdao Central Hospital1432023-05-082026-01-05
Insulin for Hyperglycemia in Stroke Trial
Analog Insulin, Human insulin - Hyperglycemia, Stroke, Acute
Phase 4CompletedNational Institute of Neurosciences and Hospital, Dhaka4522021-04-052021-12-06
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
Cyanocobalamin, Dulaglutide - Glucose Intolerance, Overweight and Obesity
Phase 4CompletedThe University of Texas Health Science Center, Houston232020-05-152024-12-05
Once Weekly GLP-1 in Persons With Spinal Cord Injury
Semaglutide 1MG Injection [Ozempic], No Intervention - Spinal Cord Injuries, Insulin Resistance
Phase 4CompletedJames J. Peters Veterans Affairs Medical Center52018-10-162023-03-14
Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia
Ciprofloxacin 400 MG/200 ML Intravenous Solution, Levofloxacin 750 MG - QTc Prolongation, Hyperglycemia, Hypoglycemia
Phase 4CompletedBeni-Suef University2002018-06-012020-07-02
Peripheral Nerve Blocks for Above-the-knee Amputations
Peripheral nerve block, Intravenous Sedatives, Lateral femoral cutaneous nerve blocks - Peripheral Vascular Diseases, Hyperglycaemia (Diabetic)
Phase 4CompletedUniversity of Florida302018-02-092026-01-08
Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.
Metformin - PreDiabetes, Impaired Fasting Glucose (IFG)
Phase 4CompletedWroclaw Medical University472017-10-202022-05-27
Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
Metformin and Glimepiride (Low Dosage), Metformin and Vildagliptin (Low Dosage), Metformin and Insulin Glargine U100 (Low Dosage) - Diabetes Mellitus, Type 2
Phase 4CompletedUniversity of Jordan6872017-02-142020-02-11
Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
Dapagliflozin, Placebo - Prediabetes, Impaired Fasting Glucose
Phase 4CompletedUniversity of Guadalajara242016-10-012020-10-28
Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine
Linagliptin / Metformin Oral Tablet, Metformin - Prediabetic State, Impaired Glucose Tolerance
Phase 4CompletedUniversidad de Guanajuato312016-09-012019-09-13
Sitagliptin in Non-Diabetic Patients Undergoing General Surgery
Sitagliptin, Placebo, Supplemental insulin (insulin lispro) - Hyperglycemia
Phase 4CompletedEmory University802016-06-012018-06-27
Improving Beta Cell Function in Mexican American Women With Prediabetes
Liraglutide, Weight loss - Pre-Diabetes
Phase 4CompletedOhio State University3602016-05-012019-08-28
Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients
Insulin, insulin - Diabete Type 2, Hyperglycemia
Phase 4CompletedHospital Universitario Clinica San Rafael1162016-01-012023-03-03
Remifentanil and Glycemic Response in Cardiac Surgery
Remifentanil, Fentanyl - Heart Diseases, Hyperglycemia
Phase 4CompletedKathirvel Subramaniam1162016-01-012020-04-21
Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
Sitagliptin, Placebo, Regular Human Insulin - Hyperglycemia
Phase 4CompletedEmory University2022016-01-012019-12-23
Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
Insulin glargine, Insulin aspart, Supplemental insulin aspart - Diabetes Mellitus, Type 2
Phase 4CompletedEmory University2262015-10-012023-09-28
Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Dapagliflozin, Sliding scale insulin - Hyperglycemia Steroid-induced
Phase 4CompletedSlotervaart Hospital462015-02-012018-05-22
Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock
Hydrocortisone - Hyperglycemia
Phase 4CompletedSrinakharinwirot University802014-10-012017-10-06

Showing 20 of 93. Sign in to see all of them.

Narrower conditions

Glucose Intolerance (37)  ·  Diabetes Mellitus, Type 2 (30)  ·  Diabetes Mellitus (22)  ·  Insulin Resistance (19)  ·  Hypoglycemia (10)  ·  Obesity (8)  ·  Hypertension (7)  ·  Prediabetic State (5)  ·  Diabetes Mellitus, Type 1 (4)  ·  Metabolic Syndrome (4)  ·  Dyslipidemias (3)  ·  Myocardial Infarction (3)  ·  Overweight (3)  ·  Schizophrenia (3)

Broader conditions

Metabolic Diseases (93)  ·  Nutritional and Metabolic Diseases (93)  ·  Glucose Metabolism Disorders (92)  ·  Endocrine System Diseases (54)  ·  Diabetes Mellitus (31)  ·  Hyperinsulinism (21)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Cardiovascular Diseases (12)  ·  Signs and Symptoms (12)  ·  Vascular Diseases (12)  ·  Nutrition Disorders (11)  ·  Body Weight (10)  ·  Overnutrition (10)  ·  Pathologic Processes (10)

Interventions

Insulin Glargine (16)  ·  Insulin (15)  ·  Metformin (12)  ·  Sitagliptin Phosphate (9)  ·  Exenatide (7)  ·  Insulin Aspart (6)  ·  Insulin Lispro (6)  ·  Pioglitazone (5)  ·  dapagliflozin (4)  ·  Acarbose (3)  ·  Insulin Detemir (3)  ·  Insulin, Isophane (3)  ·  Linagliptin (3)  ·  Liraglutide (3)  ·  Vildagliptin (3)

Sponsors

Emory University (6)  ·  Karolinska Institutet (3)  ·  Novartis Pharmaceuticals (3)  ·  Baylor College of Medicine (2)  ·  Carl T. Hayden VA Medical Center (2)  ·  Cook County Health (2)  ·  Medical University of Graz (2)  ·  Nathan Kline Institute for Psychiatric Research (2)  ·  Northwestern University (2)  ·  Ohio State University (2)  ·  The University of Texas Health Science Center at San Antonio (2)  ·  University of Florida (2)  ·  University of Oslo School of Pharmacy (2)  ·  University of Pittsburgh (2)  ·  Beni-Suef University (1)

Countries

United States (50)  ·  China (4)  ·  Mexico (4)  ·  Japan (3)  ·  Sweden (3)  ·  Austria (2)  ·  Brazil (2)  ·  Canada (2)  ·  Denmark (2)  ·  Germany (2)  ·  Italy (2)  ·  Norway (2)  ·  Poland (2)  ·  South Korea (2)  ·  Thailand (2)

Top investigators

Guillermo Umpierrez, MD (5)  ·  Mark E Molitch, M.D. (2)  ·  Robert C Smith, MD PhD (2)  ·  Aaron S. Kelly, Ph.D. (1)  ·  Absalon D Gutierrez, MD (1)  ·  Adrian Vella, M.D. (1)  ·  Adriana Franzese, Dr (1)  ·  Adrienne M Lynn, FRACP (1)  ·  Ahmed A Elberry, professor (1)  ·  Amalia Gastaldelli, PhD (1)  ·  Ambika Babu, MD,MS (1)  ·  Andrew R Hoffman, MD (1)

Results publications

PMID 17513708, PMID 23435159, PMID 37526194, PMID 11889147, PMID 15793249, PMID 15823767, PMID 16123520, PMID 17229660, PMID 19156705, PMID 19158048, PMID 19190104, PMID 19318384, PMID 19336639, PMID 19454394, PMID 19719706, PMID 19814947, PMID 20039889, PMID 20200309, PMID 20409690, PMID 20457512, PMID 20536957, PMID 20557887, PMID 20923490, PMID 21228246, PMID 21861845, PMID 22040840, PMID 22223765, PMID 22232134, PMID 22456695, PMID 22475524, PMID 22681705, PMID 22688337, PMID 22871230, PMID 22992074, PMID 23186969, PMID 23200554, PMID 23877988, PMID 24035165, PMID 25168125, PMID 25466315, PMID 25835492, PMID 25838513, PMID 26116695, PMID 26197707, PMID 26336609, PMID 26492541, PMID 26620049, PMID 26656289, PMID 26786573, PMID 27405306

NIH funding

2014 (1), 2025 (1), K23HL086558 (1), R21DK082878 (1), R21DK122234 (1)